Gopalkumar Rakesh

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Gopalkumar Rakesh sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 5 completed upper quartile by trial count

Gopalkumar Rakesh: 7 sponsored US clinical trials, 2 recruiting.

Gopalkumar Rakesh sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Methamphetamine Use Disorders, with 1 trials.

Upper-quartile sponsor footprint

Gopalkumar Rakesh sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

tDCS and Urge in BFRBs

NCT07019571
RECRUITING NA

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

NCT06830980
COMPLETED NA

tDCS and Inhibitory Control in PTSD

NCT06100731
COMPLETED NA

Theta Burst Stimulation for Alcohol Use Disorder

NCT06060496
COMPLETED NA

Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)

NCT05295953
COMPLETED NA

Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder

NCT05049460
COMPLETED NA

TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)

NCT04936594

Therapeutic Areas

Methamphetamine Use Disorders 1
Repetitive Compulsive Behavior 1
HIV 1

What is open in the Gopalkumar Rakesh pipeline

2 recruiting of 7 indexed (29% open); 5 completed (71%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Methamphetamine Use Disorders (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Gopalkumar Rakesh: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Gopalkumar Rakesh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Gopalkumar Rakesh3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Gopalkumar Rakesh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Gopalkumar Rakesh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Gopalkumar Rakesh page

7 registered trials is a research-attention snapshot, not an endorsement of Gopalkumar Rakesh or any single study.

  • 2 of Gopalkumar Rakesh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Methamphetamine Use Disorders is the condition Gopalkumar Rakesh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Methamphetamine Use Disorders trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Gopalkumar Rakesh pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.